JP2008531672A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531672A5
JP2008531672A5 JP2007557589A JP2007557589A JP2008531672A5 JP 2008531672 A5 JP2008531672 A5 JP 2008531672A5 JP 2007557589 A JP2007557589 A JP 2007557589A JP 2007557589 A JP2007557589 A JP 2007557589A JP 2008531672 A5 JP2008531672 A5 JP 2008531672A5
Authority
JP
Japan
Prior art keywords
composition according
microparticle composition
microparticle
ssrna
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007557589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531672A (ja
Filing date
Publication date
Priority claimed from GB0504276A external-priority patent/GB0504276D0/en
Priority claimed from GB0511801A external-priority patent/GB0511801D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/000751 external-priority patent/WO2006092607A1/en
Publication of JP2008531672A publication Critical patent/JP2008531672A/ja
Publication of JP2008531672A5 publication Critical patent/JP2008531672A5/ja
Pending legal-status Critical Current

Links

JP2007557589A 2005-03-02 2006-03-02 医薬組成物 Pending JP2008531672A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0504276A GB0504276D0 (en) 2005-03-02 2005-03-02 Pharmaceutical composition
GB0511801A GB0511801D0 (en) 2005-06-10 2005-06-10 Pharmaceutical composition
PCT/GB2006/000751 WO2006092607A1 (en) 2005-03-02 2006-03-02 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
JP2008531672A JP2008531672A (ja) 2008-08-14
JP2008531672A5 true JP2008531672A5 (cg-RX-API-DMAC7.html) 2009-04-16

Family

ID=36353665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007557589A Pending JP2008531672A (ja) 2005-03-02 2006-03-02 医薬組成物

Country Status (8)

Country Link
US (1) US20080138431A1 (cg-RX-API-DMAC7.html)
EP (1) EP1853227B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008531672A (cg-RX-API-DMAC7.html)
AT (1) ATE438385T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006219717B2 (cg-RX-API-DMAC7.html)
CA (1) CA2599329A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006008278D1 (cg-RX-API-DMAC7.html)
WO (1) WO2006092607A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ535952A (en) 2002-04-04 2009-01-31 Coley Pharm Gmbh Immunostimulatory G,U-containing oligoribonucleotides
WO2007062107A2 (en) 2005-11-25 2007-05-31 Coley Pharmaceutical Gmbh Immunostimulatory oligoribonucleotides
EP2288381A2 (en) * 2008-05-02 2011-03-02 Cancer Research Technology Limited Products and methods for stimulating an immune response
US9770463B2 (en) 2010-07-06 2017-09-26 Glaxosmithkline Biologicals Sa Delivery of RNA to different cell types
PT3243526T (pt) 2010-07-06 2020-03-04 Glaxosmithkline Biologicals Sa Distribuição de arn para despoletar múltiplas vias imunitárias
US10487332B2 (en) 2010-07-06 2019-11-26 Glaxosmithkline Biologicals Sa Immunisation of large mammals with low doses of RNA
CN103153284B (zh) 2010-07-06 2015-11-25 诺华股份有限公司 含有其pKa值有利于RNA递送的脂质的脂质体
FI4005592T3 (fi) 2010-07-06 2023-01-13 Virionin kaltaisia kuljetuspartikkeleita itsereplikoituville rna-molekyyleille
JP5911870B2 (ja) 2010-08-31 2016-04-27 ノバルティス アーゲー 免疫原をコードするrnaの送達のためのpeg化リポソーム
KR102266691B1 (ko) 2010-10-11 2021-06-23 노파르티스 아게 항원 전달 플랫폼
JP2014522842A (ja) 2011-07-06 2014-09-08 ノバルティス アーゲー 免疫原性組み合わせ組成物およびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
NZ532274A (en) * 2001-10-03 2006-02-24 Chiron Corp Adjuvanted meningococcus compositions
SI1589934T1 (sl) * 2003-01-06 2016-02-29 Corixa Corporation Corporation Service Company Določene aminoalkil glukozaminid fosfat spojine in njih uporaba
JP2006522806A (ja) * 2003-03-26 2006-10-05 マルチセル・イミュノセラピューティクス,インコーポレイテッド 細胞死及び/又はアポトーシスを誘導するための、選択されたrnaモチーフ

Similar Documents

Publication Publication Date Title
Ho et al. Next‐generation vaccines: nanoparticle‐mediated DNA and mRNA delivery
Zeng et al. Formulation and delivery technologies for mRNA vaccines
Chen et al. Advances in the polymeric delivery of nucleic acid vaccines
Meng et al. A new developing class of gene delivery: messenger RNA-based therapeutics
Zhao et al. Enhancing mucosal immune response of Newcastle disease virus DNA vaccine using N-2-hydroxypropyl trimethylammonium chloride chitosan and N, O-carboxymethyl chitosan nanoparticles as delivery carrier
Qin et al. Recent advances in the noninvasive delivery of mRNA
CN101874112A (zh) 特别是作为免疫刺激剂/佐剂的式(Ⅰ):G1XmGn或式(Ⅱ):C1XmCn的核酸
Andresen et al. Nucleic acid delivery and nanoparticle design for COVID vaccines
AU2003219805B2 (en) Electroporation methods for introducing bioactive agents into cells
CN118001254B (zh) 靶向抗原呈递细胞的脂质组合物及其应用
Wang et al. Advances in the study of LNPs for mRNA delivery and clinical applications
Carmona-Ribeiro Cationic nanostructures for vaccines
EP1853227B1 (en) Pharmaceutical composition
Pereira et al. Advanced biopolymeric materials and nanosystems for RNA/DNA vaccines: a review
Peng et al. Pathologic Tissue Injury and Inflammation in Mice Immunized with Plasmid DNA-Encapsulated DOTAP-Based Lipid Nanoparticles
Luo et al. Unlocking delivery strategies for mRNA therapeutics
US12064511B2 (en) Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy
Kirtane et al. Improving the efficacy of cancer mRNA vaccines
Goyal et al. Advancement in polymer-based carrier for DNA vaccine
Gang et al. Research progress of polymer carriers in the field of mRNA delivery
Das et al. Emerging concepts in Leishmania vaccine adjuvants
Zhou et al. Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
Cai et al. Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunity
CN117618380B (zh) 一种无免疫原性磷脂纳米递送系统的制备与应用
Del Bene et al. From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment